摘要
目的比较阿立哌唑与氯氮平对精神分裂症患者生活质量的影响。方法将60例精神分裂症患者随机分为两组,分别给予阿立哌唑、氯氮平治疗6个月。用阳性症状与阴性症状量表(PAN SS)评定精神症状,用世界卫生组织编制的生活质量量表(WHOQOL 100)评估生活质量。结果阿立哌唑对阳性症状、一般精神病理和PAN SS总分改善与氯氮平相似,对阴性症状改善明显优于氯氮平。阿立哌唑对生活质量方面除精神支柱外均非常明显地提高,且在生理领域、心理领域和独立性领域明显优于氯氮平。结论阿立哌唑更有利于改善精神分裂症患者的生活质量。
Objective To compare the quality of life in schizophrenic patients treated with aripiprazole and closapine. Methods 60 schizophrenic patients were treated with aripiprazole or clozapine randomly for 6 months. The symptoms of schizophrenia was assessed with the positive and negative symptoms scale （PANSS）, the quality of life was measvred with WHO quality of life scale （WHOQOL100）. Results The degree of the improvement of positive＇symptoms, general psychiatric pathology and the total score of PANSS in aripiprazole group was similar with clozapine group, but the degree of the improvement of negative symptoms in aripiprazole group was higher than clozapine group. Aripiprazole can significantly improve every aspects of patient＇s life quality except domination, and aripiprazole was superior to clozapine in improvement of schizophrenic patients quality of life in aspect of physiology, psychology and independence. Conclusion Aripiprazole is favorable for schizophrenic patients to improve quality of life.
出处
《中国健康心理学杂志》
2007年第10期956-957,共2页
China Journal of Health Psychology
